Molecular genetics, recombinant DNA techniques, and genetic neurological disease

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The molecular defects responsible for Huntington's disease, the spinocerebellar degenerations, myotonic muscular dystrophy, neurofibromatosis, and tuberous sclerosis, among other major dominant inherited diseases of the nervous system, will be identified using the new techniques of molecular genetics. With synthesized nucleic acid segments complementary to portions of the patient's DNA, known as complementary DNA probes, it will be possible to identify and isolate the mutant gene responsible for a particular disease. These events are referred to as gene cloning. In addition, complex genetic regulatory mechanisms involved in cell differentiation during neuroembryogenesis will be elucidated with the application of these strategies. It is important for the clinician to become familiar with the precision and potential of these new methodologies, because they will soon influence significantly the practice of neurology.

Original languageEnglish (US)
Pages (from-to)511-520
Number of pages10
JournalAnnals of Neurology
Volume15
Issue number6
StatePublished - 1984

Fingerprint

Inborn Genetic Diseases
Recombinant DNA
Molecular Biology
Spinocerebellar Degenerations
Myotonic Dystrophy
Neurofibromatoses
Tuberous Sclerosis
Muscular Dystrophies
Huntington Disease
DNA Probes
Neurology
Nervous System Diseases
Nucleic Acids
Genes
Organism Cloning
Cell Differentiation
Complementary DNA
DNA

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Molecular genetics, recombinant DNA techniques, and genetic neurological disease. / Rosenberg, R. N.

In: Annals of Neurology, Vol. 15, No. 6, 1984, p. 511-520.

Research output: Contribution to journalArticle

@article{95e50bf990ad429bbcb915ff5975d090,
title = "Molecular genetics, recombinant DNA techniques, and genetic neurological disease",
abstract = "The molecular defects responsible for Huntington's disease, the spinocerebellar degenerations, myotonic muscular dystrophy, neurofibromatosis, and tuberous sclerosis, among other major dominant inherited diseases of the nervous system, will be identified using the new techniques of molecular genetics. With synthesized nucleic acid segments complementary to portions of the patient's DNA, known as complementary DNA probes, it will be possible to identify and isolate the mutant gene responsible for a particular disease. These events are referred to as gene cloning. In addition, complex genetic regulatory mechanisms involved in cell differentiation during neuroembryogenesis will be elucidated with the application of these strategies. It is important for the clinician to become familiar with the precision and potential of these new methodologies, because they will soon influence significantly the practice of neurology.",
author = "Rosenberg, {R. N.}",
year = "1984",
language = "English (US)",
volume = "15",
pages = "511--520",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "6",

}

TY - JOUR

T1 - Molecular genetics, recombinant DNA techniques, and genetic neurological disease

AU - Rosenberg, R. N.

PY - 1984

Y1 - 1984

N2 - The molecular defects responsible for Huntington's disease, the spinocerebellar degenerations, myotonic muscular dystrophy, neurofibromatosis, and tuberous sclerosis, among other major dominant inherited diseases of the nervous system, will be identified using the new techniques of molecular genetics. With synthesized nucleic acid segments complementary to portions of the patient's DNA, known as complementary DNA probes, it will be possible to identify and isolate the mutant gene responsible for a particular disease. These events are referred to as gene cloning. In addition, complex genetic regulatory mechanisms involved in cell differentiation during neuroembryogenesis will be elucidated with the application of these strategies. It is important for the clinician to become familiar with the precision and potential of these new methodologies, because they will soon influence significantly the practice of neurology.

AB - The molecular defects responsible for Huntington's disease, the spinocerebellar degenerations, myotonic muscular dystrophy, neurofibromatosis, and tuberous sclerosis, among other major dominant inherited diseases of the nervous system, will be identified using the new techniques of molecular genetics. With synthesized nucleic acid segments complementary to portions of the patient's DNA, known as complementary DNA probes, it will be possible to identify and isolate the mutant gene responsible for a particular disease. These events are referred to as gene cloning. In addition, complex genetic regulatory mechanisms involved in cell differentiation during neuroembryogenesis will be elucidated with the application of these strategies. It is important for the clinician to become familiar with the precision and potential of these new methodologies, because they will soon influence significantly the practice of neurology.

UR - http://www.scopus.com/inward/record.url?scp=0021240779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021240779&partnerID=8YFLogxK

M3 - Article

VL - 15

SP - 511

EP - 520

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 6

ER -